Related Experiment Videos
Comparative activity of the 4-quinolones
1Department of Microbiology, United Medical School, Guy's Hospital, London, United Kingdom.
Reviews of Infectious Diseases
|January 1, 1988
Summary
The 4-quinolone antibiotics show consistent minimal inhibitory concentrations (MICs) globally. Most common pathogens are susceptible, with variations mainly due to acquired resistance, making them effective antimicrobial agents.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- The 4-quinolone class of antibiotics, including ciprofloxacin and ofloxacin, are widely used antimicrobials.
- Understanding their spectrum of activity and resistance patterns is crucial for effective clinical application.
Purpose of the Study:
- To determine the global minimal inhibitory concentrations (MICs) of several 4-quinolones against a range of clinically relevant bacteria.
- To assess the susceptibility patterns of various pathogens to these agents, considering acquired resistance.
Main Methods:
- Determination of MICs for ciprofloxacin, enoxacin, norfloxacin, ofloxacin, pefloxacin, difloxacin, A-56620, and CI-934.
- Testing against a broad spectrum of bacterial species, including Enterobacteriaceae, Pseudomonas, Staphylococcus, Streptococcus, Haemophilus, Neisseria, Chlamydia, Mycoplasma, and anaerobes.
Main Results:
- MICs for 4-quinolones are globally consistent, with variations linked to acquired resistance.
- Enterobacteriaceae and most intestinal pathogens are sensitive; ciprofloxacin shows high activity against Pseudomonas aeruginosa.
- Haemophilus influenzae, Branhamella catarrhalis, Neisseria species are highly sensitive, while activity against Chlamydia, Mycoplasma, and anaerobes is variable or poor.
Conclusions:
- 4-quinolones exhibit broad-spectrum activity, with notable efficacy against Gram-negative bacteria and some Gram-positive organisms.
- Resistance patterns, particularly in Pseudomonas and anaerobes, require consideration for optimal therapeutic use.
- The study confirms the reliable antimicrobial profiles of these 4-quinolones worldwide.